Skip to main content
Neil Gross, MD, Otolaryngology (ENT), Houston, TX, University of Texas M.D. Anderson Cancer Center

NeilGrossMD

Otolaryngology (ENT) Houston, TX

Head & Neck Oncologic Surgery

Professor, Head and Neck Surgery

Dr. Gross is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gross' full profile

Already have an account?

Education & Training

  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Otolaryngology - Head and Neck Surgery, 1999 - 2003
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 1998
  • Washington University
    Washington UniversityB.A., Biology, with Honors, 1994

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2006 - Present
  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License Active through 2024
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • NY State Medical License
    NY State Medical License 2003 - 2006
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
  • ACGMEOtolaryngology

Awards, Honors, & Recognition

  • Faculty Teaching Award, Department of Head and Neck Surgery 2014
  • Fellow-At-Large American Head and Neck Society, 2013
  • Honor Award AAO-HNS, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Scott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
  • Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Janice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
  • Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Richard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Facilitating rapid precision oncology in anaplastic thyroid cancer: Clinical implications of next generation sequencing (NGS) mutation testing and impact on survival.
    Wang J (Presenting), Gross ND, ASCO Annual Meeting, 1/1/2018
  • Tracheal recurrences in HPV positive SCC.
    Chen M (presenting), Gross ND, ASNR 56th Annual Meeting, 1/1/2018
  • Long-term Outcomes of Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Desia N (Presenting), Gross ND, American Head and Neck Society Annual Meeting, San Diego, CA, 1/1/2017
  • Join now to see all

Lectures

  • Panel: Thyroid & Parathyroid 
    Vail, CO - 1/5/2018
  • Panel: Management of HPV Positive Oropharyngeal Cancer 
    University of Colorado, Vail, CO - 1/30/2017
  • Parathyroid Cases 
    University of Colorado, Vail, CO - 1/30/2017
  • Join now to see all

Other

  • Treatment of Advanced (Stage III and IV) Head and Neck Cancer: The Oral Cavity. 
    Gross ND, Lee N, Wu A, Okuno S, UptoDate
    1/1/2016
  • Treatment of Early (Stage I and II) Head and Neck Cancer: The Oral Cavity. 
    Gross ND, Lee N, Wu A, Okuno S, UptoDate
    1/1/2016
  • Contemporary Adjunctive Cancer Therapy, 3rd. 
    Gross ND, American Academy of Otolaryngology Head and Neck Surgery
    1/1/2015
  • Join now to see all

Hospital Affiliations